Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 16

1.

Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia.

Purandare N, Burns A, Morris J, Perry EP, Wren J, McCollum C.

Am J Psychiatry. 2012 Mar;169(3):300-8. doi: 10.1176/appi.ajp.2011.11010009. Erratum in: Am J Psychiatry. 2012 Mar 1;169(3):338.

PMID:
22193532
2.

Galantamine for vascular cognitive impairment.

Craig D, Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004746. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD004746.

PMID:
16437493
3.

Donepezil for vascular cognitive impairment.

Malouf R, Birks J.

Cochrane Database Syst Rev. 2004;(1):CD004395. Review.

PMID:
14974068
4.

Folic acid with or without vitamin B12 for cognition and dementia.

Malouf M, Grimley EJ, Areosa SA.

Cochrane Database Syst Rev. 2003;(4):CD004514. Review. Update in: Cochrane Database Syst Rev. 2008;(4):CD004514.

PMID:
14584018
5.

Rivastigmine for Alzheimer's disease.

Birks JS, Grimley Evans J.

Cochrane Database Syst Rev. 2015 Apr 10;4:CD001191. doi: 10.1002/14651858.CD001191.pub3. Review.

PMID:
25858345
6.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154.

PMID:
12917950
7.

Galantamine for vascular cognitive impairment.

Birks J, Craig D.

Cochrane Database Syst Rev. 2006 Jan 25;4:CD004746. doi: 10.1002/14651858.CD004746.pub2. Review.

PMID:
23862185
8.

Metal protein attenuating compounds for the treatment of Alzheimer's dementia.

Sampson EL, Jenagaratnam L, McShane R.

Cochrane Database Syst Rev. 2012 May 16;5:CD005380. doi: 10.1002/14651858.CD005380.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;2:CD005380.

9.

Metal protein attenuating compounds for the treatment of Alzheimer's dementia.

Sampson EL, Jenagaratnam L, McShane R.

Cochrane Database Syst Rev. 2014 Feb 21;2:CD005380. doi: 10.1002/14651858.CD005380.pub5. Review.

PMID:
24563468
10.

Selegiline for Alzheimer's disease.

Birks J, Flicker L.

Cochrane Database Syst Rev. 2003;(1):CD000442. Review.

PMID:
12535396
11.

Rivastigmine for Alzheimer's disease.

Birks JS, Chong LY, Grimley Evans J.

Cochrane Database Syst Rev. 2015 Sep 22;9:CD001191. [Epub ahead of print] Review.

PMID:
26393402
12.

Galantamine for Alzheimer's disease and mild cognitive impairment.

Loy C, Schneider L.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001747. Review.

PMID:
16437436
13.

Rivastigmine for vascular cognitive impairment.

Birks J, McGuinness B, Craig D.

Cochrane Database Syst Rev. 2013 May 31;5:CD004744. doi: 10.1002/14651858.CD004744.pub3. Review.

PMID:
23728651
14.

Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).

Arevalo-Rodriguez I, Smailagic N, Roqué I Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S.

Cochrane Database Syst Rev. 2015 Mar 5;3:CD010783. doi: 10.1002/14651858.CD010783.pub2. Review.

PMID:
25740785
15.

Dietary interventions as a neuroprotective therapy for the delay of the onset of cognitive decline in older adults: an umbrella review protocol.

Krause D, Roupas P.

JBI Database System Rev Implement Rep. 2015 Mar 12;13(2):74-83. doi: 10.11124/jbisrir-2015-1899. Review. No abstract available.

PMID:
26447035
16.

Cognitive deterioration in adult epilepsy: Does accelerated cognitive ageing exist?

Breuer LE, Boon P, Bergmans JW, Mess WH, Besseling RM, de Louw A, Tijhuis AG, Zinger S, Bernas A, Klooster DC, Aldenkamp AP.

Neurosci Biobehav Rev. 2016 May;64:1-11. doi: 10.1016/j.neubiorev.2016.02.004. Epub 2016 Feb 18. Review.

PMID:
26900650
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk